GID SVF-2 Device System

DEVICE2 trials

Sponsors

GID BIO, Inc.

Conditions

Covid19Osteoarthritis, Knee

Phase 3

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

Active, not recruitingNCT04440189

GID BIO, Inc.Osteoarthritis, Knee

Start: 2020-10-15End: 2025-06-30Updated: 2025-04-23

Unknown Phase

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Post COVID-19

WithdrawnNCT06940765

GID BIO, Inc.Covid19

Start: 2021-09-30End: 2022-05-31Updated: 2025-04-23